Evidence map›Paper›PMID 40455127›Full record

ReviewProbiotics and antimicrobial proteins2026

Exploring the Multitude: A Review on Different Categorization of Probiotics.

Raja Karukuvelraja, Natarajan Saranya

Abstract readReview
PubMed Publisher
In one paragraph

Review in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Molecular Mechanisms of Probiotic Action Against Gastrointestinal Cancers.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Raja KarukuvelrajaDepartment of Biotechnology, Nehru Arts and Science College, Coimbatore, Tamil Nadu, 641105, India.
Natarajan SaranyaDepartment of Biotechnology, Nehru Arts and Science College, Coimbatore, Tamil Nadu, 641105, India. nascsaranya.n@nehrucolleges.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Probiotics are living microbes that provide health benefits when administered in appropriate quantities. Probiotics maintain a balanced gut microbiota that has a remarkable influence on human physiology and nutrition; also, they have been recognised for their other advantages, including their beneficial effects on the skin, oral cavity, brain, immune system, vaginal tract, and so on. Probiotic microbes have been consumed by humans through traditionally fermented meals for many millennia. Bacteria, such as lactic acid bacteria, are considered innocuous and provide beneficial compounds for human health. Increased understanding of the gut microbiota has led to remarkable advancements in probiotic research. A wide range of probiotic products, including functional foods, nutritional products, and food supplements, have previously been introduced to the worldwide market. Probiotics provide numerous health benefits, extending beyond improved nutritional status to managing and preventing disorders in both intestinal and other non-intestinal sites such as the skin, brain, and oral cavity. The emphasis on the benefits of bacteria for health has recently moved from live, viable probiotics to inactive probiotic-derived microbes. These recently discovered non-viable bacteria are gerobiotics, psychobiotics, immunobiotics, oralbiotics, cardiobiotics, dermabiotics, urogeniobiotics, and gastrobiotics. Metabolites from probiotics can improve physiological health and provide therapeutic effects. The current review provides an overview of the various categories based on the potential health benefits.

Indexed as

ProbioticsAnimalsBacteriaGastrointestinal MicrobiomeHumansCardiobioticsDermabioticsGastrobioticsGerobioticsImmunobioticsOralbioticsProbioticsPsychobioticsUrogeniobiotics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.